Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy

References

• Willett EV, Morton LM, Hartge P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008;122:2062–2070.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–578.
   PubMed Web of Science ®Google Scholar
• Han X, Stevens J, Bradshaw PT. Body mass index, weight change, and survival in non-Hodgkin lymphoma patients in Connecticut women. Nutr Cancer 2013;65:43–50.
   PubMed Web of Science ®Google Scholar
• Stanisavljevic N, Marisavljevic D. Weight and body composition changes during R-CHOP chemotherapy in patients with non-Hodgkin's lymphoma and their impact on dose intensity and toxicity. J BUON 2010;15:290–296.
   PubMed Web of Science ®Google Scholar
• Chin Y, Liu J, Tai J, et al. The significance of body weight change in non-Hodgkins lymphoma. Anticancer Res 1999;19: 5607–5610.
   PubMed Web of Science ®Google Scholar
• Lynce F, Pehlivanova M, Catlett J, et al. Obesity in adult lymphoma survivors. Leuk Lymphoma 2012;53:569–574.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346: 235–242.
   PubMed Web of Science ®Google Scholar
• Healthy People: 2020 topics & objectives – cancer. Accessed 9 July 2014 from: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId = 5
   Google Scholar
• Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev 2001;2:219–229.
   PubMedGoogle Scholar
• Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763–778.
   PubMed Web of Science ®Google Scholar
• Nissen M, Shapiro A, Swenson K. Changes in weight and body composition in women receiving chemotherapy for breast cancer. Clin Breast Cancer 2011;11:52–60.
   PubMed Web of Science ®Google Scholar
• Smith M. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 2004;63: 742–745.
   PubMed Web of Science ®Google Scholar
• Sagstuen H, Aass N, Fossa SD, et al. Blood pressure and body mass index in long-term survivors of testicular cancer. J Clin Oncol 2005;23:4980–4990.
   PubMed Web of Science ®Google Scholar
• Vardy J, Chiew KS, Galica J, et al. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 2006;94: 1011–1015.
   PubMed Web of Science ®Google Scholar
• Nord C, Fossa SD, Egeland T. Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer 2003;88:36–41.
   PubMed Web of Science ®Google Scholar
• Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist 2010;15:556–565.
   PubMed Web of Science ®Google Scholar
• Courneya KS, Sellar CM, Stevinson C, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 2009;27:4605–4612.
   PubMed Web of Science ®Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695–708.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global database on body mass index. Accessed 28 June 2013 from: http://apps.who.int/bmi/index.jsp?introPage = intro_3.html
   Google Scholar
• Romano P, Roos L, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075–1079.
   PubMed Web of Science ®Google Scholar
• Moreno A, Colon-Otero G, Solberg LA, Jr. The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard? Oncologist 2000;5:238–49.
   PubMedGoogle Scholar
• Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. New Engl J Med 2011;364:2392–2404.
   PubMed Web of Science ®Google Scholar
• Katzmarzyk PH, Hebebrand J, Bouchard C. Spousal resemblance in the Canadian population: implications for the obesity epidemic. Int J Obesity 2002;26:241–246.
   Web of Science ®Google Scholar
• Chang VW, Christakis NA. Self-perception of weight appropriateness in the United States. Am J Prevent Med 2003;24: 332–339.
   PubMed Web of Science ®Google Scholar
• Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metabol Cardiovasc Dis 2008;18:388–395.
   PubMed Web of Science ®Google Scholar
• Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol 2014.
   Web of Science ®Google Scholar
• Salminen E, Bishop M, Poussa T, et al. Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer. Eur J Clin Nutr 2004;58:137–144.
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Segal RJ, Vallis M, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 2014;32:2231–2239.
   PubMed Web of Science ®Google Scholar
• Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6–28.
   PubMed Web of Science ®Google Scholar